To test whether the H19 rs2839698 polymorphism could has effects on disease progression; we then analyze the association between rs2839698 genotypes and the tumor size, clinical stage and tumor grade of RCC in the patient group. This evidence concerns the gene H19 and renal cell adenocarcinoma.